Pelthos Therapeutics Inc. (PTHS)
PTHS Stock Price Chart
Explore Pelthos Therapeutics Inc. interactive price chart. Choose custom timeframes to analyze PTHS price movements and trends.
PTHS Company Profile
Discover essential business fundamentals and corporate details for Pelthos Therapeutics Inc. (PTHS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
2 Jul 2025
Employees
4.00
Website
https://pelthos.comCEO
Scott Plesha
Description
Pelthos Therapeutics Inc. operates as a biopharmaceutical enterprise dedicated to developing and commercializing innovative medical treatments that address significant, unmet patient needs. Its primary offerings include ZELSUVMI, a medication specifically indicated for the treatment of molluscum contagiosum in individuals aged one year and older. Furthermore, the company leverages NITRICIL, an exclusive technological platform grounded in nitric oxide research. Established in 2002, this Durham, North Carolina-based firm was previously known as Channel Therapeutics Corporation, before rebranding to Pelthos Therapeutics Inc. in July 2025.
PTHS Financial Timeline
Browse a chronological timeline of Pelthos Therapeutics Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$2.95, while revenue estimate is $15.17m.
Earnings released on 14 May 2026
EPS came in at -$3.09 surpassing the estimated -$3.45 by +10.43%, while revenue for the quarter reached $10.91m , beating expectations by +4.49%.
Earnings released on 19 Mar 2026
EPS came in at -$2.83 surpassing the estimated -$3.95 by +28.35%, while revenue for the quarter reached $9.39m , beating expectations by +3.28%.
Earnings released on 13 Nov 2025
EPS came in at -$5.30 falling short of the estimated -$0.67 by -691.04%, while revenue for the quarter reached $7.41m , missing expectations by -29.08%.
Earnings released on 13 Aug 2025
EPS came in at -$5.38 falling short of the estimated -$3.10 by -73.55%.
Stock split effective on 2 Jul 2025
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
PTHS Stock Performance
Access detailed PTHS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
